The REUMAVID study enters its second phase. A second survey is being launched in the European countries participating in REUMAVID. The first to start with the second phase of the study was the United Kingdom, which began data collection on February the 4th. Second, France launched its survey on February the 9th, followed by Italy on February the 11th. The other participating countries (Spain, Portugal, Greece and Cyprus) are finalising the details of adapting the surveys to the national context to be launched before the end of the month.
This second study will allow us to compare the evolution of rheumatic disease patients in Europe with their first reaction to the beginning of the COVID-19 pandemic, and will allow us to examine how the measures implemented in each country to cope with the health, economic and social crisis have affected the health status, wellbeing and quality of life of people with rheumatic diseases.